RNAi technology, a key biological breakthrough of the last decade, has revolutionized basic biology and gene function studies. It also has the potential to enable significant advances in drug discovery and therapeutics. Viral-based shRNA is one RNAi approach that allows researchers to perform long-term gene silencing in a myriad of cell lines, even primary cells and non-dividing cells. Join this educational discussion hosted by the Senior Editor of G&P and DRUG DISCOVERY & DEVELOPMENT magazines along with a panel of distinguished scientists. You'll hear our expert panelists discuss how to harness the power of viral shRNA delivery systems and offer insights on important experimental design parameters. Potential topics of discussion include: • Viral systems used for shRNA; • Features to consider in selecting viral systems; • Important experimental parameters for success; • Applications for viral-mediated RNAi. Access Now Presented by: In association with: MODERATOR: Patrick McGee Senior Editor Drug Discovery & Development G&P PANELISTS: William Hahn, MD, PhD Assistant Professor of Medicine Harvard Medical School Department of Medical Oncology Dana-Farber Cancer Institute Brian Latario, MSc Lab Head Genome & Proteome Sciences Department Novartis Institute for Biomedical Research John Rossi, PhD Chair and Professor Division of Molecular Biology Beckman Research Institute of City of Hope